Viewing nowCombinationExcresbar Tablet 5/80/5 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Korea Hyutex Pharmaceutical Co., Ltd.

MFDS item code 202106226 · Approved 2021.08.27 · Insurance code 649105360
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular risk
This drug is used for patients with essential hypertension whose blood pressure is not adequately controlled despite using amlodipine and valsartan combination therapy. Additionally, rosuvastatin is used as an adjunct in patients with hypercholesterolemia and dyslipidemia that are not controlled by diet, and is also effective for homozygous familial hypercholesterolemia and primary dysbetalipoproteinemia. Rosuvastatin lowers cholesterol levels in hypercholesterolemic patients, delays the progression of atherosclerosis, and helps reduce the risk of cardiovascular diseases, strokes, myocardial infarction, and vascular revascularization procedures. Therefore, this drug is used to effectively control blood pressure and blood lipids to improve cardiovascular health.
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate products may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout treatment. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. 2. Elderly patients: No dosage adjustment is required. 3. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This drug may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so use should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this drug, severely impaired liver or kidney function, or pregnant or nursing women should not take this medication. Patients with sodium or fluid depletion should correct their conditions before taking this medication, and if symptoms of hypotension appear during use, appropriate measures should be taken immediately. Patients with high potassium levels or kidney function issues should be cautious when taking this drug with potassium supplements or potassium-sparing diuretics, and should regularly check blood potassium levels. Patients with a history of kidney transplantation or angioedema require special attention when taking this drug, and if symptoms of angioedema occur, use should be stopped immediately. Patients with heart failure or those who have had a recent myocardial infarction should evaluate kidney function before taking this drug, and administration should be carried out carefully according to symptoms. This medication can cause musculoskeletal adverse reactions such as myalgia, myopathy, and rarely rhabdomyolysis, so any unusual symptoms like muscle pain should be reported to healthcare professionals immediately. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. This drug can interact with several medications, so patients taking other medications should consult their doctor or pharmacist. Pregnant or nursing women should not take this medication, and women who could become pregnant should use appropriate contraception. The safety and efficacy of this medication have not been established in children under 18 years of age, so it is not recommended. For older adults, it is advisable to start with a low dose and gradually increase, as excessive blood pressure reduction could increase the risk of stroke and other complications. In case of overdose, severe hypotension, shock, arrhythmias, and other symptoms may occur, so emergency treatment should be sought immediately, and activated charcoal administration or gastric lavage may be implemented if necessary.
Peripheral edema, heat sensation, increase in ALT, increase in AST, increase in serum creatinine, flank pain, neck pain, dizziness, sensory impairment, nasopharyngitis, rash, rhinopharyngitis, influenza, hypersensitivity, visual disturbances, anxiety, headache, drowsiness, orthostatic dizziness, abnormal sensations, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, erythema, hyperhidrosis, rash, pruritus, joint swelling, back pain, arthritis, muscle cramps, lethargy, frequent urination, polyuria, erectile dysfunction, edema, localized edema, facial edema, fatigue, flushing, weakness, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, taste disorders, peripheral neuropathy, muscular hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gum hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, serum sickness, serum potassium increase, vasculitis, increased liver function tests, angioedema, bullous dermatitis, myalgia, renal failure, kidney damage, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, memory loss, peripheral neuropathy, cough, dyspnea, thrombocytopenia, jaundice, transaminase increase, eosinophilia with systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, post-marketing cognitive impairment, severe myasthenia gravis, oculobulbar myasthenia gravis, weight loss, weight gain, increase in blood creatinine, aphasia, spinal stenosis, oral bleeding, stomatitis, carpal tunnel syndrome, chills, facial flushing, hyperglycemia, increased triglycerides, hypercholesterolemia, increased blood pressure, exacerbation of hypertension, neck/shoulder pain, leg fractures, toe fractures, spinal fractures, fractures, osteomyelitis, skin infections, dermatitis of unspecified origin, localized skin reactions, palpitations, exacerbation of angina, auditory disturbances, vestibular neuritis, overactive bladder, retinal detachment, vitreous detachment, neoplasm-like condition of unspecified skin tumor, prostatic hypertrophy, shingles, herniated disc, lacerations, pain, malaise, chest pain, weakness, facial flushing, weight loss, weight gain, increased liver enzymes, urination disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, headache, dizziness, constipation, nausea, abdominal pain, myalgia, myopathy, rhabdomyolysis, weakness, joint pain, fatigue, numbness, abnormal sensations, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to protect it from air and moisture. It is also advisable to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug’s effectiveness.
Pale pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Korea Hyutex Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.